Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6665 | 1384 | 45.3 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
132 | 22818 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANGIOTENSIN 1 7 | Author keyword | 549 | 78% | 26% | 360 |
2 | ANGIOTENSIN CONVERTING ENZYME 2 | Author keyword | 176 | 70% | 10% | 145 |
3 | MAS RECEPTOR | Author keyword | 130 | 79% | 6% | 83 |
4 | ACE2 | Author keyword | 67 | 51% | 7% | 94 |
5 | ANG 1 7 | Author keyword | 44 | 73% | 2% | 33 |
6 | HYPERTENS VASC DIS | Address | 39 | 39% | 6% | 78 |
7 | AVE 0991 | Author keyword | 37 | 100% | 1% | 14 |
8 | ANGIOTENSIN CONVERTING ENZYME 2 ACE2 | Author keyword | 33 | 74% | 2% | 25 |
9 | SCI TECHNOL NANOBIOPHARMACEUT | Address | 27 | 92% | 1% | 11 |
10 | A 779 | Author keyword | 26 | 80% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANGIOTENSIN 1 7 | 549 | 78% | 26% | 360 | Search ANGIOTENSIN+1+7 | Search ANGIOTENSIN+1+7 |
2 | ANGIOTENSIN CONVERTING ENZYME 2 | 176 | 70% | 10% | 145 | Search ANGIOTENSIN+CONVERTING+ENZYME+2 | Search ANGIOTENSIN+CONVERTING+ENZYME+2 |
3 | MAS RECEPTOR | 130 | 79% | 6% | 83 | Search MAS+RECEPTOR | Search MAS+RECEPTOR |
4 | ACE2 | 67 | 51% | 7% | 94 | Search ACE2 | Search ACE2 |
5 | ANG 1 7 | 44 | 73% | 2% | 33 | Search ANG+1+7 | Search ANG+1+7 |
6 | AVE 0991 | 37 | 100% | 1% | 14 | Search AVE+0991 | Search AVE+0991 |
7 | ANGIOTENSIN CONVERTING ENZYME 2 ACE2 | 33 | 74% | 2% | 25 | Search ANGIOTENSIN+CONVERTING+ENZYME+2+ACE2 | Search ANGIOTENSIN+CONVERTING+ENZYME+2+ACE2 |
8 | A 779 | 26 | 80% | 1% | 16 | Search A+779 | Search A+779 |
9 | ANGIOTENSIN PEPTIDES | 20 | 49% | 2% | 29 | Search ANGIOTENSIN+PEPTIDES | Search ANGIOTENSIN+PEPTIDES |
10 | ANGIOTENSIN1 7 | 19 | 76% | 1% | 13 | Search ANGIOTENSIN1+7 | Search ANGIOTENSIN1+7 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACE2 | 158 | 66% | 11% | 147 |
2 | MAS RECEPTOR | 148 | 84% | 6% | 80 |
3 | CONVERTING ENZYME 2 | 133 | 72% | 8% | 104 |
4 | COUPLED RECEPTOR MAS | 73 | 85% | 3% | 39 |
5 | ENZYME RELATED CARBOXYPEPTIDASE | 73 | 77% | 4% | 50 |
6 | CARBOXYPEPTIDASE | 53 | 28% | 12% | 165 |
7 | ANGIOTENSIN CONVERTING ENZYME 2 ACE2 | 47 | 86% | 2% | 24 |
8 | NATRIURETIC ACTION | 47 | 86% | 2% | 24 |
9 | ACE2 EXPRESSION | 45 | 94% | 1% | 16 |
10 | INCREASED CIRCULATING ANGIOTENSIN 1 7 | 42 | 94% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system | 2013 | 67 | 199 | 87% |
Angiotensin type 2 receptor (AT(2)R) and receptor Mas: a complex liaison | 2015 | 4 | 56 | 48% |
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis | 2008 | 157 | 65 | 92% |
Angiotensin-(1-7): beyond the cardio-renal actions | 2013 | 43 | 136 | 58% |
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets | 2014 | 9 | 204 | 92% |
Angiotensin-(I-7) in kidney disease: a review of the controversies | 2012 | 33 | 93 | 84% |
ACE2: more of Ang-(1-7) or less Ang II? | 2011 | 44 | 75 | 95% |
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good | 2011 | 55 | 147 | 75% |
ACE2, angiotensin-(1-7), and Mas: the other side of the coin | 2013 | 16 | 89 | 92% |
Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular Diseases | 2010 | 49 | 58 | 95% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPERTENS VASC DIS | 39 | 39% | 5.6% | 78 |
2 | SCI TECHNOL NANOBIOPHARMACEUT | 27 | 92% | 0.8% | 11 |
3 | HYPERTENS VASC | 16 | 17% | 6.1% | 84 |
4 | HIPERTENSAO | 12 | 42% | 1.7% | 23 |
5 | SCI TECHNOL NANOBIOPHARMACEUT INCT NA | 9 | 83% | 0.4% | 5 |
6 | SCI TECHNOL INCT NANOBIOFAR | 8 | 100% | 0.4% | 5 |
7 | CARDIOVASC EXCELLENCE | 6 | 33% | 1.2% | 16 |
8 | INCT NANOBIOFAR | 6 | 100% | 0.3% | 4 |
9 | SINGLE MOL IMAGING | 4 | 67% | 0.3% | 4 |
10 | BIOL FISIOPATOL MOL | 4 | 41% | 0.5% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000138678 | HYPERTENS RENAL EXCELLENCE//URINARY ANGIOTENSINOGEN//RECEPTOR SIGNAL TRANSDUCT |
2 | 0.0000132789 | NA ATPASE//SECOND SODIUM PUMP//ANG 3 4 |
3 | 0.0000129180 | PROLYLCARBOXYPEPTIDASE//PRCP//ANGIOTENSINASE C |
4 | 0.0000122703 | ANGIOTENSIN IV//AT4 RECEPTOR//AMINOPEPTIDASE A |
5 | 0.0000117078 | AT2 RECEPTOR//COMPOUND 21//ANGIOTENSIN RECEPTORS |
6 | 0.0000116656 | TELMISARTAN//ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER//CLIN TRIAL MANAGEMENTITABASHI KU |
7 | 0.0000091776 | ADRENAL RENIN//ANGIOTENSINOGEN//TISSUE RENIN |
8 | 0.0000088538 | OCULAR RENIN ANGIOTENSIN SYSTEM//REN 2 RAT//S PHARMACOL MOL BIOL |
9 | 0.0000085452 | MTUS1//ATIP//INVERSE PROBABILITY OF TREATMENT WEIGHT |
10 | 0.0000082181 | CD143//ANGIOTENSIN I CONVERTING ENZYME//TESTICULAR ACE |